Boston Scientific (NYSE:BSX) will report earnings before markets open on Thursday, July 25th. Boston Scientific Corporation develops, manufactures, and markets minimally invasive medical devices. The Company’s products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation.
Here is your Cheat Sheet to Boston Scientific Earnings:
Earnings Expectations: Analysts expect earnings of $0.09 per share on revenues of $1.78 billion.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.1 to a profit $0.09. For the current year, the average estimate is a profit of $0.41, which is the same as the estimate ninety days ago.
Here’s how Boston Scientific has been performing on an annual basis:
|Revenue ($) in millions||8,050||8,188||7,806||7,622||7,249|
|Diluted EPS ($)||-1.38||-0.68||-0.70||0.29||-2.89|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012||Mar. 31, 2013|
|Revenue ($) in millions||1,828.00||1,735.00||1,821.00||1,761.00|
|Diluted EPS ($)||-2.39||-0.52||0.04||-0.26|
Boston Scientific has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)